<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.BM updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.BM</link>
    <description>q-bio.BM updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.BM" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Tue, 11 Nov 2025 03:47:50 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Mon, 10 Nov 2025 00:00:00 -0500</pubDate>
    <skipDays>
      <day>Sunday</day>
      <day>Saturday</day>
    </skipDays>
    <item>
      <title>A Standardized Benchmark for Multilabel Antimicrobial Peptide Classification</title>
      <link>https://arxiv.org/abs/2511.04814</link>
      <description>arXiv:2511.04814v1 Announce Type: cross 
Abstract: Antimicrobial peptides have emerged as promising molecules to combat antimicrobial resistance. However, fragmented datasets, inconsistent annotations, and the lack of standardized benchmarks hinder computational approaches and slow down the discovery of new candidates. To address these challenges, we present the Expanded Standardized Collection for Antimicrobial Peptide Evaluation (ESCAPE), an experimental framework integrating over 80.000 peptides from 27 validated repositories. Our dataset separates antimicrobial peptides from negative sequences and incorporates their functional annotations into a biologically coherent multilabel hierarchy, capturing activities across antibacterial, antifungal, antiviral, and antiparasitic classes. Building on ESCAPE, we propose a transformer-based model that leverages sequence and structural information to predict multiple functional activities of peptides. Our method achieves up to a 2.56% relative average improvement in mean Average Precision over the second-best method adapted for this task, establishing a new state-of-the-art multilabel peptide classification. ESCAPE provides a comprehensive and reproducible evaluation framework to advance AI-driven antimicrobial peptide research.</description>
      <guid isPermaLink="false">oai:arXiv.org:2511.04814v1</guid>
      <category>cs.LG</category>
      <category>cs.AI</category>
      <category>q-bio.BM</category>
      <pubDate>Mon, 10 Nov 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>cross</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:creator>Sebastian Ojeda, Rafael Velasquez, Nicol\'as Aparicio, Juanita Puentes, Paula C\'ardenas, Nicol\'as Andrade, Gabriel Gonz\'alez, Sergio Rinc\'on, Carolina Mu\~noz-Camargo, Pablo Arbel\'aez</dc:creator>
    </item>
    <item>
      <title>LG-NuSegHop: A Local-to-Global Self-Supervised Pipeline For Nuclei Instance Segmentation</title>
      <link>https://arxiv.org/abs/2511.04892</link>
      <description>arXiv:2511.04892v1 Announce Type: cross 
Abstract: Nuclei segmentation is the cornerstone task in histology image reading, shedding light on the underlying molecular patterns and leading to disease or cancer diagnosis. Yet, it is a laborious task that requires expertise from trained physicians. The large nuclei variability across different organ tissues and acquisition processes challenges the automation of this task. On the other hand, data annotations are expensive to obtain, and thus, Deep Learning (DL) models are challenged to generalize to unseen organs or different domains. This work proposes Local-to-Global NuSegHop (LG-NuSegHop), a self-supervised pipeline developed on prior knowledge of the problem and molecular biology. There are three distinct modules: (1) a set of local processing operations to generate a pseudolabel, (2) NuSegHop a novel data-driven feature extraction model and (3) a set of global operations to post-process the predictions of NuSegHop. Notably, even though the proposed pipeline uses { no manually annotated training data} or domain adaptation, it maintains a good generalization performance on other datasets. Experiments in three publicly available datasets show that our method outperforms other self-supervised and weakly supervised methods while having a competitive standing among fully supervised methods. Remarkably, every module within LG-NuSegHop is transparent and explainable to physicians.</description>
      <guid isPermaLink="false">oai:arXiv.org:2511.04892v1</guid>
      <category>eess.IV</category>
      <category>cs.CV</category>
      <category>q-bio.BM</category>
      <pubDate>Mon, 10 Nov 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>cross</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <arxiv:journal_reference>Asia Pacific Signal and Information Processing Association (APSIPA), 2025 http://www.apsipa.org</arxiv:journal_reference>
      <dc:creator>Vasileios Magoulianitis, Catherine A. Alexander, Jiaxin Yang, C. -C. Jay Kuo</dc:creator>
    </item>
  </channel>
</rss>
